Reham Helwa

431 total citations
19 papers, 322 citations indexed

About

Reham Helwa is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Reham Helwa has authored 19 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Reham Helwa's work include Galectins and Cancer Biology (5 papers), Cancer-related Molecular Pathways (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). Reham Helwa is often cited by papers focused on Galectins and Cancer Biology (5 papers), Cancer-related Molecular Pathways (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). Reham Helwa collaborates with scholars based in Egypt, Norway and Germany. Reham Helwa's co-authors include Jörg D. Hoheisel, Amal Kamal Abdel‐Aziz, Eman M. Mantawy, Riham S. Said, Stian Knappskog, Karsten Brand, Stephan Macher‐Goeppinger, Peter Schirmacher, Susanne Dihlmann and Jürgen Weitz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Experimental Neurology.

In The Last Decade

Reham Helwa

18 papers receiving 320 citations

Peers

Reham Helwa
Francesca Pia Caruso Italy
Xingrui Li China
Xiaoning Zhang China
Rochelle L. Tiedemann United States
Dennis Poel Netherlands
Mengxi Xiu China
Fernando López-Calderón Spain
Blaž Grošelj Slovenia
Kunming Wen China
Junyi Yin China
Francesca Pia Caruso Italy
Reham Helwa
Citations per year, relative to Reham Helwa Reham Helwa (= 1×) peers Francesca Pia Caruso

Countries citing papers authored by Reham Helwa

Since Specialization
Citations

This map shows the geographic impact of Reham Helwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reham Helwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reham Helwa more than expected).

Fields of papers citing papers by Reham Helwa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reham Helwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reham Helwa. The network helps show where Reham Helwa may publish in the future.

Co-authorship network of co-authors of Reham Helwa

This figure shows the co-authorship network connecting the top 25 collaborators of Reham Helwa. A scholar is included among the top collaborators of Reham Helwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reham Helwa. Reham Helwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Helwa, Reham, et al.. (2024). A Case of Euthyroid Graves’ Ophthalmopathy With Negative Thyroid Antibodies. Cureus. 16(11). e73527–e73527.
2.
Helwa, Reham, et al.. (2022). PTEN mutations prevalence in HER2-positive breast cancer patients. Revista de Senología y Patología Mamaria. 36(1). 100410–100410. 3 indexed citations
3.
Helwa, Reham, et al.. (2022). Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications. World Journal of Surgical Oncology. 20(1). 276–276. 6 indexed citations
4.
Helwa, Reham, et al.. (2022). Galectins dysregulation: A way for cancer cells to invade and pervade. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 30(3). 129–135. 2 indexed citations
5.
Helwa, Reham, et al.. (2022). Homemade plasmid Miniprep solutions for affordable research in low-fund laboratories. AMB Express. 12(1). 137–137. 1 indexed citations
6.
Osman, Ahmed, et al.. (2022). In-house protocol: spin-based viral RNA purification. AMB Express. 12(1). 70–70. 2 indexed citations
7.
Helwa, Reham, Liv B. Gansmo, Merete Bjørnslett, et al.. (2021). Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer. Biomarkers. 26(4). 302–308. 4 indexed citations
8.
Røsland, Gro Vatne, Sissel E. Dyrstad, Deusdedit Tusubira, et al.. (2019). Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC. SHILAP Revista de lepidopterología. 7(1). 6–6. 56 indexed citations
9.
Ali, Mohamed A. M., et al.. (2017). The Synonymous Isocitrate Dehydrogenase 1 315C>T SNP Confers an Adverse Prognosis in Egyptian Adult Patients with NPM1-/CEBPA-Negative Acute Myeloid Leukemia. Indian Journal of Hematology and Blood Transfusion. 34(2). 240–252. 4 indexed citations
10.
Helwa, Reham, Anette Heller, Stian Knappskog, & Andrea S. Bauer. (2017). Tumor cells interact with red blood cells via galectin-4 - a short report. Cellular Oncology. 40(4). 401–409. 18 indexed citations
11.
12.
Helwa, Reham, Liv B. Gansmo, Pål Romundstad, et al.. (2016). MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer. Scientific Reports. 6(1). 33153–33153. 8 indexed citations
13.
Abdel‐Aziz, Amal Kamal, Eman M. Mantawy, Riham S. Said, & Reham Helwa. (2016). The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries. Experimental Neurology. 283(Pt A). 129–141. 48 indexed citations
14.
15.
Abdelrahman, Ibrahim Y., et al.. (2015). Induction of P3NS1 Myeloma Cell Death and Cell Cycle Arrest by Simvastatin and/or γ-Radiation. Asian Pacific Journal of Cancer Prevention. 16(16). 7103–7110. 10 indexed citations
16.
Helwa, Reham, et al.. (2015). Expression profiling of cancer-related galectins in acute myeloid leukemia. Tumor Biology. 36(10). 7929–7939. 19 indexed citations
17.
18.
Helwa, Reham & Jörg D. Hoheisel. (2010). Analysis of DNA–protein interactions: from nitrocellulose filter binding assays to microarray studies. Analytical and Bioanalytical Chemistry. 398(6). 2551–2561. 31 indexed citations
19.
Bandapalli, Obul Reddy, Susanne Dihlmann, Reham Helwa, et al.. (2009). Transcriptional activation of the β‐ catenin gene at the invasion front of colorectal liver metastases. The Journal of Pathology. 218(3). 370–379. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Pia Caruso Breakdown of academic impact, for papers by Xingrui Li Breakdown of academic impact, for papers by Xiaoning Zhang Breakdown of academic impact, for papers by Rochelle L. Tiedemann Breakdown of academic impact, for papers by Dennis Poel Breakdown of academic impact, for papers by Mengxi Xiu Breakdown of academic impact, for papers by Fernando López-Calderón Breakdown of academic impact, for papers by Blaž Grošelj Breakdown of academic impact, for papers by Kunming Wen Breakdown of academic impact, for papers by Junyi Yin
Rankless by CCL
2026